Suchergebnisse - "Oppel, Felix"

PubPharm (15)

1

p53 Pathway Inactivation Drives SMARCB1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 Inhibition

enthalten in: Molecular cancer therapeutics | 2022

von Oppel, F. | Shao, S. | Gendreizig, S. | +8

2

Viral and Clinical Oncology of Head and Neck Cancers

enthalten in: Current oncology reports | 2022

von Goon, P. | Schürmann, M. | Oppel, F. | +8

3

Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts

enthalten in: Cells | 2021

von Yao, W. | Qian, X. | Ochsenreither, S. | +8

4

suz12 inactivation in p53- and nf1-deficient zebrafish accelerates the onset of malignant peripheral nerve sheath tumors and expands the spectrum of tumor types

enthalten in: Disease models & mechanisms | 2020

von Oppel, F. | Ki, D. | Zimmerman, M. | +6

5

Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck

enthalten in: International journal of biological sciences | 2020

von Xu, Q. | Fang, M. | Zhu, J. | +9

6

Stem Cell-Induced Inflammation in Cholesteatoma is Inhibited by the TLR4 Antagonist LPS-RS

enthalten in: Cells | 2020

von Schürmann, M. | Greiner, J. | Volland-Thurn, V. | +4

7

Mechanisms underlying synergy between DNA topoisomerase I-targeted drugs and mTOR kinase inhibitors in NF1-associated malignant peripheral nerve sheath tumors

enthalten in: Oncogene | 2019

von Ki, D. | Oppel, F. | Durbin, A. | +1

8

Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignancies

enthalten in: PLoS genetics | 2019

von Oppel, F. | Tao, T. | Shi, H. | +6

9

Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer

enthalten in: Cells | 2019

von Ehrenberg, K. | Gao, J. | Oppel, F. | +18

10

Specific Targeting of Oncogenes Using CRISPR Technology

enthalten in: Cancer research | 2018

von Oppel, F. | Schürmann, M. | Goon, P. | +2